Technical Assistance Webinar: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)

Date and Time August 9, 202312:00–1:00 p.m. ET OverviewA technical assistance webinar will be held for prospective applicants of the following Notice of Funding Opportunity (NOFO): Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required) . National Institute of Mental Health staff will be available to answer questions…

Read More

Wearable RLS Therapy Offers Respite to Drug-Refractory Patients, Studies Show

Noctrix Health Inc’s wearable TOMAC therapy for the treatment of restless legs syndrome (RLS) was found to be safe and effective, providing a “substantial reduction” in symptoms, for adult patients with RLS refractory to medications, according to two studies published in Sleep. The two papers feature the results from the RESTFUL study, a multicenter, randomized,…

Read More

Is Tackling Chronic Pain a Prerequisite for Insomnia Treatment?

Interview by Alyx Arnett Physical pain can be a significant obstacle to a good night’s sleep, particularly for individuals with comorbid insomnia. Research reveals that half of those affected by insomnia also experience chronic pain.1 Many healthcare professionals believe that addressing pain is a prerequisite for improving sleep, but is this perception valid?  To shed…

Read More

Two Key Measurements Could Predict Cardiovascular Disease Risk in OSA Patients

Researchers have found that people with obstructive sleep apnea have an increased cardiovascular risk due to reduced blood oxygen levels, largely explained by interrupted breathing.  Obstructive sleep apnea has long been associated with an increased risk of cardiovascular issues, including heart attack, stroke, and death, but the findings from this study, partially supported by the…

Read More

Researchers Make Strides in Understanding SIDS Causes

An initiative to solve a several thousand-year-old medical mystery—what causes sudden or unexplained infant deaths (SUID)—has led to new insights that recently were presented at the 6th annual SIDS Summit. The initiative brings together the world’s leading researchers on sudden infant death syndrome (SIDS) and infant deaths with private-sector data scientists, who together mix data…

Read More